FT-IR studies were accomplished to confirm the synthesis of CS-g-P, B-GHS, CS-g-P/B-GHS, FLZ drug, and FLZ-loaded CS-g-P/B-GHS; the results are presented in Fig.
1. Figure
1a shows the typical spectra of CS-g-P, and it exhibits characteristic peaks at 1634 cm
− 1 and 1539 cm
− 1 matching the stretching and bending modes of the (C-O) and (-NH) of the amide (-CONH) group, which indicate the successful graft of proline in CS molecule [
22]. The FT-IR spectrum of B-GHS shows the absorbance peaks at 1658 and 1554 cm
− 1, respective to the -CO stretching and -NH bending modes of amide -CONH groups. The peaks at 543 cm
− 1, 931 cm
− 1, 1076 cm
− 1, 1719 cm
− 1, 2525 cm
− 1, 3033 cm
− 1, and 3366 cm
− 1, which corresponds to the functional groups of the biotin and glutathione molecules by evidence from the previous reports [
23,
24]. The peaks were due to the bond formation between the biotin and glutathione as biotinylated glutathione conjugation (Fig.
1b). The FT-IR spectrum of the CS-g-P/ B-GHS shows a highly intense peak arising at 1703 cm
− 1, and it is corresponding to the C = O stretch, confirming esterification between B-GHS and CS-g-P moieties [
25]. Also, the presence of other characteristic peaks 1719 cm
− 1, 1076 cm
− 1, and 931 cm
− 1 is responsible for B-GHS, which resembles the confirmation of B-GHS functionalization in the CS-g-P moiety (Fig.
1c). FT-IR spectrum of fluconazole drug shows the vibrations of the different functional moieties present in the compound could be attributed to broad peak due to intramolecular hydrogen-bonded O-H stretching frequency in the range of 3600 − 2500 cm
− 1 [
26]. The 1619 and 1514 cm
− 1 are due to the C = C stretch aromatic ring, and 1502 cm
− 1 and 1420 cm
− 1 are due to the triazole ring stretch. The triazole ring was breathing at 1138 cm
− 1 and 1273 cm
− 1 for the C-F stretch of the FLZ molecule (Fig.
1d) [
27,
28]. The FLZ-loaded CS-g-P/ B-GHS attributed the maximum peak of FLZ retained, such as 1273 cm
− 1, 1420 cm
− 1, 967, and 846 cm
− 1 peaks, which confirms that FLZ drug loaded in the CS-g-P/ B-GHS carrier (Fig.
1e).